Free shipping on all orders over $ 500

Omaveloxolone

Cat. No. M10081

All AbMole products are for research use only, cannot be used for human consumption.

Omaveloxolone Structure
Synonym:

RTA-408

Size Price Availability Quantity
10mM*1mL in DMSO USD 117  USD117 In stock
1mg USD 49  USD49 In stock
2mg USD 67  USD67 In stock
5mg USD 90  USD90 In stock
10mg USD 139  USD139 In stock
25mg USD 267  USD267 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Omaveloxolone (RTA 408) is a first-in-class antioxidant inflammatory modulator (AIM) that activates Nrf2 and inhibits nitric oxide (NO). Omaveloxolone inhibits osteoclastogenesis by inhibiting the STING-dependent NF-κb signaling pathway.

Omaveloxolone (RTA-408) is a member of the synthetic oleanane triterpenoid class of compounds and an activator of nuclear factor erythroid 2 [NF-E2]-related factor 2 (Nrf2). Omaveloxolone (RTA-408) potently increases expression of Nrf2 target genes and reverses IFNγ-mediated suppression of Gclc expression in RAW 264.7 cells. In a panel of eight human tumor cell lines, Omaveloxolone inhibits growth with an average GI50 value of 260 nM and induces apoptosis.

Product Citations
Chemical Information
Molecular Weight 554.71
Formula C33H44F2N2O3
CAS Number 1474034-05-3
Solubility (25°C) DMSO 90 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Brandon L Probst, et al. PLoS One. RTA 408, A Novel Synthetic Triterpenoid with Broad Anticancer and Anti-Inflammatory Activity

[2] Devorah C Goldman, et al. Radiat Res. The triterpenoid RTA 408 is a robust mitigator of hematopoietic acute radiation syndrome in mice

[3] Scott A Reisman, et al. Radiat Res. Topical application of the synthetic triterpenoid RTA 408 protects mice from radiation-induced dermatitis

[4] Scott A Reisman, et al. Arch Dermatol Res. Topical application of the synthetic triterpenoid RTA 408 activates Nrf2 and induces cytoprotective genes in rat skin

Related Keap1-Nrf2 Products
CDDO-TFEA

CDDO-TFEA (RTA 404; TP-500) is a trifluoroacetamide derivative of CDDO with enhanced ability to cross the blood-brain barrier. CDDO is an Nrf2 activator that inhibits proliferation and induces differentiation and apoptosis in various cancer cells. CDDO-TFEA can enhance Nrf2 expression and signaling in various neurodegenerative disease models.

KI696 isomer 

KI696 isomer is the less active isomer of KI696.

TAT-14

TAT-14 is a 14-mer peptide that acts as Nrf2 activator with an anti-inflammatory effect.

[D-Asp3]-Microcystin-LR

Microcystin-[D-Asp3]-LR/Microcystin A is a cyanotoxin.

Keap1-Nrf2 probe

Keap1-Nrf2 probe is a fluorescent Keap1-Nrf2 probe.

  Catalog
Abmole Inhibitor Catalog




Keywords: Omaveloxolone, RTA-408 supplier, Keap1-Nrf2, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.